ZIM Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	434.13	19.47	96	64.21	34.2
Short-Term Investments	-	0.9	2.84	-	-
Cash & Short-Term Investments	434.13	20.37	98.84	64.21	34.2
Cash Growth	2031.63%	-79.40%	53.95%	87.72%	145.62%
Accounts Receivable	1,090	1,069	1,035	987.12	977.47
Other Receivables	-	0.76	0.34	0.28	0.39
Receivables	1,090	1,070	1,035	987.4	978.08
Inventory	937.75	864.7	812.63	537.06	752.84
Prepaid Expenses	-	24.01	18.3	17.55	9.81
Other Current Assets	295.83	334.04	311.49	303.27	346.43
Total Current Assets	2,758	2,313	2,276	1,909	2,121
Property, Plant & Equipment	2,152	2,024	1,804	1,216	1,069
Long-Term Investments	0.5	0.5	0.52	0.52	0.52
Goodwill	1.69	1.69	1.69	1.69	1.69
Other Intangible Assets	419.49	321.74	224.9	139.21	103.49
Long-Term Deferred Tax Assets	4.6	-	-	-	-
Other Long-Term Assets	57.58	59.25	160.13	149.3	120.57
Total Assets	5,394	4,720	4,468	3,416	3,416
Accounts Payable	729.29	695.06	623.81	582.39	810.71
Accrued Expenses	8.59	101.38	78.83	83.93	51.18
Short-Term Debt	-	524.61	550.4	228.8	173.45
Current Portion of Long-Term Debt	813.96	194.04	157.12	120.63	150.4
Current Portion of Leases	27.43	35.64	24.72	15.72	14.07
Current Income Taxes Payable	25.76	29.2	-	-	20.66
Current Unearned Revenue	-	3.85	4.88	3.66	4.48
Other Current Liabilities	298.89	79.86	154.5	72.74	234.17
Total Current Liabilities	1,904	1,664	1,594	1,108	1,459
Long-Term Debt	415.88	403.01	356.01	246.25	189.23
Long-Term Leases	8.32	20.7	29.5	10.18	7.22
Long-Term Deferred Tax Liabilities	104.2	110.5	101.01	48.03	3.63
Total Liabilities	2,432	2,198	2,081	1,412	1,659
Common Stock	535	487.26	487.26	487.26	162.42
Additional Paid-In Capital	-	80.3	80.3	80.3	409.89
Retained Earnings	-	1,701	1,585	1,416	1,177
Comprehensive Income & Other	2,427	253.62	234.97	19.61	8.23
Total Common Equity	2,962	2,522	2,387	2,003	1,757
Minority Interest	0.01	0.01	0	-	-
Shareholders' Equity	2,962	2,522	2,387	2,003	1,757
Total Liabilities & Equity	5,394	4,720	4,468	3,416	3,416
Total Debt	1,266	1,178	1,118	621.58	534.37
Net Cash (Debt)	-831.46	-1,158	-1,019	-557.38	-500.17
Net Cash Per Share	-16.95	-23.76	-20.91	-11.44	-10.26
Filing Date Shares Outstanding	49.85	48.73	48.73	48.73	48.73
Total Common Shares Outstanding	49.85	48.73	48.73	48.73	48.73
Working Capital	854.16	649.43	682.23	801.61	662.27
Book Value Per Share	59.41	51.77	49.00	41.12	36.06
Tangible Book Value	2,540	2,199	2,161	1,863	1,652
Tangible Book Value Per Share	50.96	45.13	44.35	38.23	33.90
Land	-	96.16	96.16	96.16	96.16
Buildings	-	819.87	790.03	503.21	471.4
Machinery	-	1,364	1,338	1,018	943.73
Construction In Progress	-	440.54	235.16	178.39	50.97

Source: S&P Global Market Intelligence. Standard template. Financial Sources.